BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 8732163)

  • 21. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
    Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
    Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathecal gene therapy for malignant leptomeningeal neoplasia.
    Ram Z; Walbridge S; Oshiro EM; Viola JJ; Chiang Y; Mueller SN; Blaese RM; Oldfield EH
    Cancer Res; 1994 Apr; 54(8):2141-5. PubMed ID: 8174120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiosensitization of rat glioma with bromodeoxycytidine and adenovirus expressing herpes simplex virus-thymidine kinase delivered by slow, rate-controlled positive pressure infusion.
    Brust D; Feden J; Farnsworth J; Amir C; Broaddus WC; Valerie K
    Cancer Gene Ther; 2000 May; 7(5):778-88. PubMed ID: 10830725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of protamine to augment adenovirus-mediated cancer gene therapy.
    Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
    Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
    Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene.
    Ezzeddine ZD; Martuza RL; Platika D; Short MP; Malick A; Choi B; Breakefield XO
    New Biol; 1991 Jun; 3(6):608-14. PubMed ID: 1655012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
    Miura F; Moriuchi S; Maeda M; Sano A; Maruno M; Tsanaclis AM; Marino R; Glorioso JC; Yoshimine T
    Gene Ther; 2002 Dec; 9(24):1653-8. PubMed ID: 12457278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
    Kuriyama N; Kuriyama H; Julin CM; Lamborn KR; Israel MA
    Cancer Res; 2001 Mar; 61(5):1805-9. PubMed ID: 11280727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene.
    Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL
    Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term rat survival after malignant brain tumor regression by retroviral gene therapy.
    Izquierdo M; Cortés M; de Felipe P; Martín V; Díez-Guerra J; Talavera A; Perez-Higueras A
    Gene Ther; 1995 Jan; 2(1):66-9. PubMed ID: 7712334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eradication of murine brain tumors by direct inoculation of concentrated high titer-recombinant retrovirus harboring the herpes simplex virus thymidine kinase gene.
    Tamura K; Tamura M; Ikenaka K; Yoshimatsu T; Miyao Y; Nanmoku K; Shimizu K
    Gene Ther; 2001 Feb; 8(3):215-22. PubMed ID: 11313793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites.
    Li S; Gao Y; Tokuyama T; Yamamoto J; Yokota N; Yamamoto S; Terakawa S; Kitagawa M; Namba H
    Cancer Lett; 2007 Jun; 251(2):220-7. PubMed ID: 17196326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.
    Tjuvajev JG; Chen SH; Joshi A; Joshi R; Guo ZS; Balatoni J; Ballon D; Koutcher J; Finn R; Woo SL; Blasberg RG
    Cancer Res; 1999 Oct; 59(20):5186-93. PubMed ID: 10537296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
    Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J
    Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel magnetic resonance imaging contrasts for monitoring response to gene therapy in rat glioma.
    Gröhn OH; Valonen PK; Lehtimäki KK; Väisänen TH; Kettunen MI; Ylä-Herttuala S; Kauppinen RA; Garwood M
    Cancer Res; 2003 Nov; 63(22):7571-4. PubMed ID: 14633668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cells producing recombinant retrovirus with thymidine kinase gene from Herpes simplex virus suitable for human cancer gene therapy.
    Hlavatý J; Hlubinová K; Bies J; Altaner C
    Neoplasma; 1999; 46(6):329-34. PubMed ID: 10732860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials.
    Dewey RA; Morrissey G; Cowsill CM; Stone D; Bolognani F; Dodd NJ; Southgate TD; Klatzmann D; Lassmann H; Castro MG; Löwenstein PR
    Nat Med; 1999 Nov; 5(11):1256-63. PubMed ID: 10545991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suicide gene therapy of ovarian cancer: an experimental study in rats using retroviral-mediated transfer of herpes simplex virus thymidine kinase gene.
    Nagy HJ; Panis Y; Fabre M; Klatzmann D; Houssin D; Soubrane O
    Anticancer Res; 2000; 20(6B):4633-8. PubMed ID: 11205314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo.
    Dilber MS; Abedi MR; Christensson B; Björkstrand B; Kidder GM; Naus CC; Gahrton G; Smith CI
    Cancer Res; 1997 Apr; 57(8):1523-8. PubMed ID: 9108455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Suicide gene therapy for glioma using HSV-tk/GCV system].
    Xu L; Ge K; Zheng Z
    Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):353-7. PubMed ID: 10920915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.